Peripheral Vasopressors in Septic Shock: Faster Start, Very Low-Certainty Evidence
This meta-analysis of observational cohorts finds no mortality signal and low extravasation rates with peripheral vasopressors, but its pooled estimates are too imprecise to support firm practice claims.
📅 Journal publication: Oct 2026(online Oct 30, 2026)·Last updated: Nov 16, 2026
Peripheral vasopressors offer a rapid, safe start in septic shock.
Central venous catheters (CVCs) for vasopressors delay hemodynamic stabilization and pose procedural risks. Peripheral vasopressor delivery reduced initiation time by 1.4-2.1 hours without compromising safety, showing low extravasation rates (0%-5.5%). Peripheral vasopressors may be a viable initial option in septic shock, but evidence is of very low certainty due to heterogeneity and observational data. Peripheral vasopressors can swiftly initiate treatment in septic shock, potentially avoiding CVC-related risks.
📊 Deep Analysis Available
Subscribers get the full breakdown: study design, outcomes, pharmacist implications, clinical pearls, GRADE evidence grade, and a downloadable PDF report. Cancel anytime.
Free account, no credit card. Includes 1 full deep analysis every month.
Authors:Nayel A, Alqurain A, Muhammad A, Hakami A, Ahmed R, Al-Atawi S, Abdeltawab A, Aljohani M, Ariahi G, Metwaly A, Syoty M, Alhuqbani A, Albalushi A, Al-Hazmy B
Citation:Nayel A, Alqurain A, Muhammad A, et al. Safety and efficiency of peripheral versus central line vasopressor administration in septic shock: a systematic review and meta-analysis. Journal of critical care medicine (Universitatea de Medicina si Farmacie din Targu-Mures). 2026;12(4):487-497. doi:10.62838/jccm-2026-0036